FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387472272> ?p ?o ?g. }

• W4387472272 abstract "Pre-eclampsia affects 2%-8% of pregnancies and is one of the leading causes of maternal and perinatal morbidity and mortality. First-trimester screening using an algorithm that combines maternal characteristics, mean arterial blood pressure, uterine artery pulsatility index and biomarkers (pregnancy-associated plasma protein-A and placental growth factor) is the method that achieves a greater diagnostic accuracy. It has been shown that daily salicylic acid administration before 16 weeks in women at a high risk for pre-eclampsia can reduce the incidence of preterm pre-eclampsia. However, no previous studies have evaluated the impact of routine first-trimester combined screening for pre-eclampsia with placental growth factor after being implemented in the clinical practice.This was a multicenter cohort study conducted in eight different maternities across Spain. Participants in the reference group were prospectively recruited between October 2015 and September 2017. Participants in the study group were retrospectively recruited between March 2019 and May 2021. Pre-eclampsia risk was calculated between 11+0 and 13+6 weeks using the Gaussian algorithm combining maternal characteristics, mean arterial pressure, uterine arteries pulsatility index, pregnancy-associated plasma protein-A and placental growth factor. Patients with a risk greater than 1/170 were prescribed daily salicylic acid 150 mg until 36 weeks. Patients in the reference group did not receive salicylic acid during gestation.A significant reduction was observed in preterm pre-eclampsia (OR 0.47; 95% CI: 0.30-0.73), early-onset (<34 weeks) pre-eclampsia (OR 0.35; 95% CI: 0.16-0.77), preterm small for gestational age newborn (OR 0.57; 95% CI: 0.40-0.82), spontaneous preterm birth (OR 0.72; 95% CI: 0.57-0.90), and admission to intensive care unit (OR 0.55; 95% CI: 0.37-0.81). A greater treatment adherence resulted in a significant reduction in adverse outcomes.Routine first-trimester screening for pre-eclampsia with placental growth factor leads to a reduction in preterm pre-eclampsia and other pregnancy complications. Aspirin treatment compliance has a great impact on the effectiveness of this screening program." @default.
• W4387472272 created "2023-10-11" @default.
• W4387472272 creator A5004845966 @default.
• W4387472272 creator A5010370605 @default.
• W4387472272 creator A5019458745 @default.
• W4387472272 creator A5022593370 @default.
• W4387472272 creator A5025667146 @default.
• W4387472272 creator A5030571449 @default.
• W4387472272 creator A5035263374 @default.
• W4387472272 creator A5048080710 @default.
• W4387472272 creator A5057950690 @default.
• W4387472272 creator A5065027545 @default.
• W4387472272 creator A5066460946 @default.
• W4387472272 creator A5070140819 @default.
• W4387472272 creator A5071397558 @default.
• W4387472272 creator A5080618772 @default.
• W4387472272 creator A5082488254 @default.
• W4387472272 creator A5087467612 @default.
• W4387472272 creator A5088921346 @default.
• W4387472272 creator A5089225236 @default.
• W4387472272 creator A5093032200 @default.
• W4387472272 date "2023-10-09" @default.
• W4387472272 modified "2023-10-17" @default.
• W4387472272 title "Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor" @default.
• W4387472272 cites W1983413616 @default.
• W4387472272 cites W2019033274 @default.
• W4387472272 cites W2019636038 @default.
• W4387472272 cites W2061506872 @default.
• W4387472272 cites W2080542014 @default.
• W4387472272 cites W2144825657 @default.
• W4387472272 cites W2171322051 @default.
• W4387472272 cites W2730504020 @default.
• W4387472272 cites W2750924434 @default.
• W4387472272 cites W2790948098 @default.
• W4387472272 cites W2811016670 @default.
• W4387472272 cites W2913050504 @default.
• W4387472272 cites W2946525881 @default.
• W4387472272 cites W2987938051 @default.
• W4387472272 cites W3003132229 @default.
• W4387472272 cites W301622561 @default.
• W4387472272 cites W3022805179 @default.
• W4387472272 cites W3026786153 @default.
• W4387472272 cites W3033055862 @default.
• W4387472272 cites W3036125070 @default.
• W4387472272 cites W3039401173 @default.
• W4387472272 cites W3136022532 @default.
• W4387472272 cites W3183431596 @default.
• W4387472272 cites W4221062821 @default.
• W4387472272 cites W4282594427 @default.
• W4387472272 cites W4288428230 @default.
• W4387472272 cites W4294116629 @default.
• W4387472272 doi "https://doi.org/10.1111/aogs.14687" @default.
• W4387472272 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37814344" @default.
• W4387472272 hasPublicationYear "2023" @default.
• W4387472272 type Work @default.
• W4387472272 citedByCount "0" @default.
• W4387472272 crossrefType "journal-article" @default.
• W4387472272 hasAuthorship W4387472272A5004845966 @default.
• W4387472272 hasAuthorship W4387472272A5010370605 @default.
• W4387472272 hasAuthorship W4387472272A5019458745 @default.
• W4387472272 hasAuthorship W4387472272A5022593370 @default.
• W4387472272 hasAuthorship W4387472272A5025667146 @default.
• W4387472272 hasAuthorship W4387472272A5030571449 @default.
• W4387472272 hasAuthorship W4387472272A5035263374 @default.
• W4387472272 hasAuthorship W4387472272A5048080710 @default.
• W4387472272 hasAuthorship W4387472272A5057950690 @default.
• W4387472272 hasAuthorship W4387472272A5065027545 @default.
• W4387472272 hasAuthorship W4387472272A5066460946 @default.
• W4387472272 hasAuthorship W4387472272A5070140819 @default.
• W4387472272 hasAuthorship W4387472272A5071397558 @default.
• W4387472272 hasAuthorship W4387472272A5080618772 @default.
• W4387472272 hasAuthorship W4387472272A5082488254 @default.
• W4387472272 hasAuthorship W4387472272A5087467612 @default.
• W4387472272 hasAuthorship W4387472272A5088921346 @default.
• W4387472272 hasAuthorship W4387472272A5089225236 @default.
• W4387472272 hasAuthorship W4387472272A5093032200 @default.
• W4387472272 hasBestOaLocation W43874722721 @default.
• W4387472272 hasConcept C126322002 @default.
• W4387472272 hasConcept C131872663 @default.
• W4387472272 hasConcept C167734588 @default.
• W4387472272 hasConcept C188816634 @default.
• W4387472272 hasConcept C2776871010 @default.
• W4387472272 hasConcept C2777025900 @default.
• W4387472272 hasConcept C2777218350 @default.
• W4387472272 hasConcept C2779234561 @default.
• W4387472272 hasConcept C2781207646 @default.
• W4387472272 hasConcept C2781276381 @default.
• W4387472272 hasConcept C46973012 @default.
• W4387472272 hasConcept C54355233 @default.
• W4387472272 hasConcept C71924100 @default.
• W4387472272 hasConcept C84393581 @default.
• W4387472272 hasConcept C86803240 @default.
• W4387472272 hasConceptScore W4387472272C126322002 @default.
• W4387472272 hasConceptScore W4387472272C131872663 @default.
• W4387472272 hasConceptScore W4387472272C167734588 @default.
• W4387472272 hasConceptScore W4387472272C188816634 @default.
• W4387472272 hasConceptScore W4387472272C2776871010 @default.
• W4387472272 hasConceptScore W4387472272C2777025900 @default.
• W4387472272 hasConceptScore W4387472272C2777218350 @default.
• W4387472272 hasConceptScore W4387472272C2779234561 @default.

• next